Skip to main content
logo
CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
83.85
+2.52 (3.10%)
At close: Nov 6, 2026, 4:00 PM EST
84.18
+0.33 (0.39%)
After-hours: Nov 6, 2026, 7:58 PM EST

CVS Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Capitalization
107,284109,595131,99591,370100,74295,61987,26185,41956,49079,10274,142100,374101,61389,67788,62695,422122,449125,204121,506132,839136,274
Market Cap Growth (YoY)
7.59%14.62%51.26%6.97%78.34%20.88%17.69%-14.90%-44.41%-11.79%-16.34%5.19%-17.02%-28.38%-27.06%-28.17%-10.15%11.81%10.61%34.65%52.43%
Enterprise Value
167,694172,140198,719160,890171,444164,342156,001157,516129,676146,843143,027168,479165,694155,202147,582150,731173,860184,705186,389196,619202,401
Last Close Price
83.8585.08102.0870.2577.0072.5565.6763.8441.7757.8653.7471.8870.5261.8260.7164.7380.6282.0179.2286.0887.28

Price Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
9.779.9326.9931.1656.98-19.2616.1812.2415.7710.3113.7112.1810.3929.8923.3128.40-14.6616.5217.23
Forward PE
9.9810.5513.5610.0311.5411.3911.2411.487.779.218.069.619.398.128.048.4210.6711.0111.0312.2212.88
PS Ratio
0.260.260.320.230.250.240.230.230.150.220.210.280.280.260.260.290.380.400.400.450.47
PB Ratio
1.331.361.651.181.341.311.131.110.751.050.991.351.331.201.211.331.711.761.611.791.81
P/FCF Ratio
6.897.0411.2312.3612.9015.2018.2614.388.93-14.0612.33-7.945.015.49-6.427.668.208.65
P/OCF Ratio
5.735.868.938.849.4710.5011.539.756.20-9.199.22-6.364.324.76-5.666.567.027.46
PEG Ratio
0.781.001.140.890.760.660.750.490.612.472.011.831.921.581.371.182.051.711.881.892.15

EV Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
0.400.410.480.400.430.420.410.420.350.400.400.470.470.450.440.460.540.590.610.660.70
EV/EBITDA Ratio
9.709.9511.9110.4411.7211.1411.1611.2910.2810.308.819.888.988.327.927.728.719.369.5510.3210.91
EV/EBIT Ratio
13.1313.4816.3514.8417.1116.2016.7016.8816.1715.1712.2413.4211.7710.7910.229.8211.0411.9612.3213.4514.42
EV/FCF Ratio
10.7711.0616.9021.7621.9626.1232.6426.5120.50-27.1220.70-13.738.358.67-9.4711.7512.1412.86

Financial Efficiency

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
0.930.930.961.011.061.121.071.051.101.101.121.101.041.081.131.070.991.000.981.021.01
Debt / EBITDA Ratio
3.713.913.213.275.634.864.413.905.635.994.475.253.713.693.723.613.183.272.893.303.55
Debt / FCF Ratio
4.844.846.4910.6010.2412.9917.3113.6713.11-15.9010.05-7.094.654.40-3.654.674.694.83
Net Debt / Equity Ratio
0.750.750.780.860.920.970.880.890.950.970.900.930.890.860.890.820.770.720.780.870.84
Net Debt / EBITDA Ratio
3.493.493.744.324.744.784.914.925.705.124.164.033.683.433.503.012.762.593.033.393.42
Net Debt / FCF Ratio
3.883.885.309.008.8811.2114.3411.5411.3743.2912.818.446.545.663.693.384.092.623.733.994.03
Asset Turnover
1.631.631.611.601.581.541.511.491.471.461.441.471.491.441.411.401.401.351.331.291.25
Inventory Turnover
19.4020.8620.4218.3319.2919.5719.6018.0818.9819.6619.2117.6617.7717.2916.9515.4015.0715.3015.0314.1314.32
Quick Ratio
0.610.610.620.610.570.590.580.590.560.540.600.540.590.600.590.610.620.640.620.540.55
Current Ratio
0.850.850.870.870.840.830.800.820.810.800.860.810.860.860.860.920.950.940.910.880.89
Return on Equity (ROE)
14.36%14.36%6.21%3.75%2.29%0.58%5.88%6.93%6.02%6.70%9.73%10.09%11.28%11.89%4.03%5.65%5.88%4.52%11.11%11.05%11.01%
Return on Assets (ROA)
3.11%3.11%2.97%2.67%2.47%2.50%2.29%2.31%1.99%2.40%2.90%3.21%3.68%3.72%3.77%4.06%4.27%4.14%4.10%3.95%3.82%
Return on Invested Capital (ROIC)
8.22%7.06%7.02%6.04%5.41%5.22%4.38%4.65%4.02%4.96%6.21%6.84%7.77%8.22%8.54%9.13%9.59%9.76%8.38%7.99%7.60%
Return on Capital Employed (ROCE)
7.70%7.70%7.30%6.50%6.10%6.20%5.70%5.60%4.80%5.80%6.80%7.50%8.30%8.50%8.50%9.30%9.90%9.70%9.30%9.00%8.50%

Yields

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
10.23%10.07%3.71%3.21%1.75%0.49%5.19%6.18%8.17%6.34%9.70%7.29%8.21%9.63%3.35%4.29%3.52%2.62%6.82%6.05%5.80%
FCF Yield
14.51%14.20%8.91%8.09%7.75%6.58%5.48%6.96%11.20%2.13%7.11%8.11%10.23%12.60%19.94%18.23%10.98%15.57%13.06%12.19%11.55%
Dividend Yield
3.17%3.11%2.57%3.71%3.36%3.53%3.86%3.93%5.93%4.13%4.30%3.09%3.07%3.39%3.34%3.02%2.34%2.26%2.27%2.02%1.94%
Payout Ratio
31.00%39.27%29.47%28.78%28.71%-84.82%47.22%50.97%962.07%48.48%75.47%38.07%34.45%41.82%36.47%30.80%-24.43%30.67%50.54%
Buyback Yield / Dilution
-1.66%-1.73%-1.34%-1.19%-1.27%-0.79%-0.87%0.24%2.48%2.40%2.18%1.86%1.97%1.90%2.57%2.79%1.27%1.05%0.45%-0.45%-
Total Shareholder Return
1.51%1.37%1.24%2.52%2.09%2.74%2.99%4.17%8.41%6.54%6.48%4.95%5.04%5.29%5.92%5.81%3.61%3.31%2.72%1.56%1.94%
SEC Filings: 10-K · 10-Q